Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

PHASE3CompletedINTERVENTIONAL

Enrollment

503

Participants

Timeline

Start Date

January 11, 2017

Primary Completion Date

September 11, 2018

Study Completion Date

September 11, 2018

Conditions

Nocturia

Interventions

DRUG

Desmopressin ODT 25 μg

DRUG

Desmopressin ODT 50 μg

Trial Locations (1)

Investigational site (there may be other sites in this country), Tokyo